» Articles » PMID: 15242972

Postconditioning: a Form of "modified Reperfusion" Protects the Myocardium by Activating the Phosphatidylinositol 3-kinase-Akt Pathway

Overview
Journal Circ Res
Date 2004 Jul 10
PMID 15242972
Citations 162
Authors
Affiliations
Soon will be listed here.
Abstract

Brief intermittent episodes of ischemia and reperfusion, at the onset of reperfusion after a prolonged period of ischemia, confer cardioprotection, a phenomenon termed "ischemic postconditioning" (Postcond). We hypothesized that this phenomenon may just represent a modified form of reperfusion that activates the reperfusion injury salvage kinase (RISK) pathway. Isolated perfused rat hearts were subjected to: (a) 35 minutes of ischemia and 120 minutes of reperfusion, and infarct size was determined by tetrazolium staining; or (b) 35 minutes of ischemia and 7 minutes of reperfusion, and the phosphorylation states of Akt, endothelial NO synthase (eNOS), and p70S6K were determined. Postcond reduced infarct size from 51.2+/-3.4% to 31.5+/-4.1% (P<0.01), an effect comparable with ischemic preconditioning (IPC; 27.5+/-2.3%; P<0.01). Of interest, the combined protective effects of IPC and Postcond were not additive (30.1+/-4.8% with IPC+Postcond; P=NS). Inhibiting phosphatidylinositol 3-kinase (PI3K) at reperfusion using LY or Wortmannin (Wort) during the first 15 minutes of reperfusion completely abolished Postcond-induced protection (31.5+/-4.1% with Postcond versus 51.7+/-4.5% with Postcond+LY, P<0.01; 56.2+/-10.1% with Postcond+ Wort; P<0.01), suggesting that Postcond protects the heart by activating PI3K-Akt. Western blot analysis demonstrated that Postcond induced a significant increase in phosphorylation of Akt, eNOS, and p70S6K in an LY- and Wort-sensitive manner. In conclusion, we show for the first time that ischemic Postcond protects the myocardium by activating the prosurvival kinases PI3K-Akt, eNOS, and p70S6K in accordance with the RISK pathway.

Citing Articles

High-density lipoprotein protects normotensive and hypertensive rats against ischemia-reperfusion injury through differential regulation of mTORC1 and mTORC2 signaling.

Al-Othman R, Al-Jarallah A, Babiker F Front Pharmacol. 2024; 15:1398630.

PMID: 39611167 PMC: 11603114. DOI: 10.3389/fphar.2024.1398630.


Nitric oxide is involved in the cardioprotection of neonatal rat hearts, but not in neonatal ischemic postconditioning.

Doul J, Minarikova M, Charvatova Z, Maxova H Physiol Rep. 2024; 12(15):e16147.

PMID: 39097984 PMC: 11298247. DOI: 10.14814/phy2.16147.


Effect of ischaemic postconditioning on markers of myocardial injury in ST-elevation myocardial infarction: a meta-analysis.

Bergman I, Gelikas S, Wexler Y, Braver O, Boyle D, Nussinovitch U Open Heart. 2024; 11(1).

PMID: 38286569 PMC: 10826564. DOI: 10.1136/openhrt-2023-002281.


Ischemia-reperfusion injury: molecular mechanisms and therapeutic targets.

Zhang M, Liu Q, Meng H, Duan H, Liu X, Wu J Signal Transduct Target Ther. 2024; 9(1):12.

PMID: 38185705 PMC: 10772178. DOI: 10.1038/s41392-023-01688-x.


The RISK pathway leading to mitochondria and cardioprotection: how everything started.

Yellon D, Beikoghli Kalkhoran S, Davidson S Basic Res Cardiol. 2023; 118(1):22.

PMID: 37233787 PMC: 10220132. DOI: 10.1007/s00395-023-00992-5.